TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
Abstract This study suggests a modified model of TNFR1-induced complex I-mediated NFκB signaling. Evaluation of a panel of five tumor cell lines (HCT116-PIK3CAmut, SK-MEL-23, HeLa-RIPK3, HT29, D10) with TRAF2 knockout revealed in two cell lines (HT29, HeLa-RIPK3) a sensitizing effect for death recep...
Saved in:
Main Authors: | Jennifer Wagner, David Vredevoogd, Xin Yu, Dong Lu, Daniel S. Peeper, Heike M. Hermanns, Jin Wang, Harald Wajant, Daniela Siegmund |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-024-07325-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD137 Regulates NFATc1 Expression in Mouse VSMCs through TRAF6/NF-κB p65 Signaling Pathway
by: Jinchuan Yan, et al.
Published: (2015-01-01) -
Exploring TNFR1: from discovery to targeted therapy development
by: Yingying Li, et al.
Published: (2025-01-01) -
AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF-κB Pathway
by: Kai Guo, et al.
Published: (2020-01-01) -
RIPK1 in necroptosis and recent progress in related pharmaceutics
by: Kunhou Yao, et al.
Published: (2025-02-01) -
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01)